XH02

XH02 is a compound based on L6 modification. XH02 (177Lu labeled) displays exceptional tumor growth inhibition in BxPC-3 tumors[1].

Product Specifications

UNSPSC

12352211

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Cancer

Smiles

O=C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N(CC(N[C@H]2CCCNC(N)=N)=O)C)=O)CC(N)=O)=O)[C@@H](NC([C@@]([H])(NC2=O)[C@@H](C)O)=O)CCCCNC(CCOCCOCCOCCOCCNC(OCC3C4C3CCC5=C(CC4)N=NN5CCC(N6CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC6)C(N[C@@H](C(NCCOCCOCCOCCOCCC(NCCCC[C@@H]7NC([C@@H](CC8=CC=CC=C8)NC([C@H](CC(O)=O)NC(CNC([C@@H](NC7=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)CCCCNC(CCC(N[C@@H](C(O)=O)CCCCNC(CCCC9=CC=C(C=C9)C(F)(F)F)=O)=O)=O)=O)=O)=O

Molecular Formula

C137H212F3N33O41

Molecular Weight

3034.34

References & Citations

[1]Yang B, et al. 177Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy. J Med Chem. 2025 Feb 13;68 (3) :3146-3156.